Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 4
1986 6
1987 3
1988 7
1989 3
1990 11
1991 10
1992 14
1993 30
1994 31
1995 27
1996 31
1997 34
1998 45
1999 47
2000 44
2001 57
2002 56
2003 40
2004 46
2005 66
2006 75
2007 55
2008 69
2009 82
2010 76
2011 69
2012 73
2013 78
2014 56
2015 53
2016 53
2017 46
2018 51
2019 53
2020 68
2021 60
2022 42
2023 40
2024 37
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,561 results

Results by year

Filters applied: . Clear all
Page 1
Bevacizumab.
Kazazi-Hyseni F, Beijnen JH, Schellens JH. Kazazi-Hyseni F, et al. Among authors: beijnen jh. Oncologist. 2010;15(8):819-25. doi: 10.1634/theoncologist.2009-0317. Epub 2010 Aug 5. Oncologist. 2010. PMID: 20688807 Free PMC article. Review.
Methylnaltrexone.
Hendrikx JJ, Beijnen JH, Schellens JH. Hendrikx JJ, et al. Among authors: beijnen jh. Oncologist. 2009 Jul;14(7):679-82. doi: 10.1634/theoncologist.2009-0049. Epub 2009 Jul 15. Oncologist. 2009. PMID: 19605844 Free article. Review. No abstract available.
Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up.
van den Berg JH, Heemskerk B, van Rooij N, Gomez-Eerland R, Michels S, van Zon M, de Boer R, Bakker NAM, Jorritsma-Smit A, van Buuren MM, Kvistborg P, Spits H, Schotte R, Mallo H, Karger M, van der Hage JA, Wouters MWJM, Pronk LM, Geukes Foppen MH, Blank CU, Beijnen JH, Nuijen B, Schumacher TN, Haanen JBAG. van den Berg JH, et al. Among authors: beijnen jh. J Immunother Cancer. 2020 Aug;8(2):e000848. doi: 10.1136/jitc-2020-000848. J Immunother Cancer. 2020. PMID: 32753545 Free PMC article. Clinical Trial.
Inhibitors of mTOR.
Klümpen HJ, Beijnen JH, Gurney H, Schellens JH. Klümpen HJ, et al. Among authors: beijnen jh. Oncologist. 2010;15(12):1262-9. doi: 10.1634/theoncologist.2010-0196. Epub 2010 Dec 8. Oncologist. 2010. PMID: 21147869 Free PMC article. Review.
Trastuzumab.
Boekhout AH, Beijnen JH, Schellens JH. Boekhout AH, et al. Among authors: beijnen jh. Oncologist. 2011;16(6):800-10. doi: 10.1634/theoncologist.2010-0035. Epub 2011 May 31. Oncologist. 2011. PMID: 21632460 Free PMC article.
Treatment Individualization in Colorectal Cancer.
van Geel RM, Beijnen JH, Bernards R, Schellens JH. van Geel RM, et al. Among authors: beijnen jh. Curr Colorectal Cancer Rep. 2015;11(6):335-344. doi: 10.1007/s11888-015-0288-z. Epub 2015 Aug 26. Curr Colorectal Cancer Rep. 2015. PMID: 26617477 Free PMC article. Review.
Inherent formulation issues of kinase inhibitors.
Herbrink M, Schellens JH, Beijnen JH, Nuijen B. Herbrink M, et al. Among authors: beijnen jh. J Control Release. 2016 Oct 10;239:118-27. doi: 10.1016/j.jconrel.2016.08.036. Epub 2016 Aug 28. J Control Release. 2016. PMID: 27578098 Review.
Cyclosporine-induced anaphylaxis.
Kuiper RA, Malingré MM, Beijnen JH, Schellens JH. Kuiper RA, et al. Among authors: beijnen jh. Ann Pharmacother. 2000 Jul-Aug;34(7-8):858-61. doi: 10.1345/aph.19302. Ann Pharmacother. 2000. PMID: 10928395
Clinical pharmacokinetics of cyclophosphamide.
de Jonge ME, Huitema AD, Rodenhuis S, Beijnen JH. de Jonge ME, et al. Among authors: beijnen jh. Clin Pharmacokinet. 2005;44(11):1135-64. doi: 10.2165/00003088-200544110-00003. Clin Pharmacokinet. 2005. PMID: 16231966 Review.
1,561 results